一名42岁患者的侵袭性浆母细胞性多发性骨髓瘤：是炎性肠病还是英夫利昔单抗治疗所致？
Aggressive plasmablastic multiple myeloma in a 42-year-old: is inflammatory bowel disease or infliximab treatment to be blamed?
作者信息
Yadav Siddhartha, Kumar Ramesh, Jaiyesimi Ishmael A, Chisti Mohammad Muhsin
机构信息
Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA.
出版信息
BMJ Case Rep. 2013 Oct 29;2013:bcr2013200607. doi: 10.1136/bcr-2013-200607.
Abstract
A man in his early 40s with a history of ulcerative colitis, treated with infliximab, was diagnosed with plasmablastic multiple myeloma. He was treated with chemotherapy and stem cell transplant but developed recurrence and ultimately died from metastatic disease. Could inflammatory bowel disease or infliximab therapy have any role in development of myeloma in this young patient? The role of inflammatory bowel disease and infliximab therapy in the development of multiple myeloma is controversial but interesting and worth considering.
摘要
一名40岁出头、有溃疡性结肠炎病史且接受英夫利昔单抗治疗的男性被诊断为浆母细胞性多发性骨髓瘤。他接受了化疗和干细胞移植，但疾病复发，最终死于转移性疾病。炎症性肠病或英夫利昔单抗治疗在这位年轻患者的骨髓瘤发生过程中会起作用吗？炎症性肠病和英夫利昔单抗治疗在多发性骨髓瘤发生中的作用存在争议，但很有趣且值得探讨。
相似文献
1
Aggressive plasmablastic multiple myeloma in a 42-year-old: is inflammatory bowel disease or infliximab treatment to be blamed?一名42岁患者的侵袭性浆母细胞性多发性骨髓瘤：是炎性肠病还是英夫利昔单抗治疗所致？
BMJ Case Rep. 2013 Oct 29;2013:bcr2013200607. doi: 10.1136/bcr-2013-200607.
2
Recurrent Fevers After Infliximab Therapy for Ulcerative Colitis.
Gastroenterology. 2016 Jan;150(1):e1-2. doi: 10.1053/j.gastro.2015.04.048. Epub 2015 Nov 25.
3
Review article: multiple myeloma and inflammatory bowel disease.
Dig Dis Sci. 2007 Sep;52(9):2022-8. doi: 10.1007/s10620-006-9165-6. Epub 2007 Apr 10.
4
Review article: Infliximab therapy for inflammatory bowel disease--seven years on.综述文章：英夫利昔单抗治疗炎症性肠病——七年回顾
Aliment Pharmacol Ther. 2006 Feb 15;23(4):451-63. doi: 10.1111/j.1365-2036.2006.02786.x.
5
Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapy.溃疡性结肠炎患者在免疫抑制治疗后发生皮肤淋巴瘤。
J Crohns Colitis. 2011 Dec;5(6):608-11. doi: 10.1016/j.crohns.2011.04.015. Epub 2011 May 18.
6
High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy.炎症性肠病患者中无反应性的高发生率限制了英夫利昔单抗治疗前结核菌素纯蛋白衍生物筛查的实用性。
Clin Gastroenterol Hepatol. 2004 Apr;2(4):309-13. doi: 10.1016/s1542-3565(04)00060-6.
7
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病：英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
8
Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab.英夫利昔单抗治疗溃疡性结肠炎并发皮肤结节病。
J Crohns Colitis. 2012 Jul;6(6):708-12. doi: 10.1016/j.crohns.2012.01.008. Epub 2012 Jan 29.
9
Development of testicular germ cell cancer following successful infliximab induction therapy for ulcerative colitis.成功使用英夫利昔单抗诱导治疗溃疡性结肠炎后发生睾丸生殖细胞癌。
J Crohns Colitis. 2011 Apr;5(2):162-4. doi: 10.1016/j.crohns.2010.11.002. Epub 2010 Dec 13.
10
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.一例溃疡性结肠炎并发坏疽性脓皮病采用联合治疗（英夫利昔单抗和手术）的病例报告。
J Crohns Colitis. 2013 Jun;7(5):421-6. doi: 10.1016/j.crohns.2012.07.021. Epub 2012 Aug 11.
引用本文的文献
1
Association between Multiple Myeloma and Ulcerative Colitis: A Cross-Sectional Analysis.多发性骨髓瘤与溃疡性结肠炎之间的关联：一项横断面分析。
Diseases. 2023 Apr 6;11(2):59. doi: 10.3390/diseases11020059.
2
A Rare Presentation of HIV-Negative Plasmablastic Lymphoma: A Diagnostic Dilemma.人类免疫缺陷病毒阴性浆母细胞淋巴瘤的罕见表现：诊断难题
Case Rep Hematol. 2019 Feb 13;2019:2907317. doi: 10.1155/2019/2907317. eCollection 2019.
本文引用的文献
1
Immunopathogenesis of inflammatory bowel disease.炎症性肠病的免疫发病机制
Self Nonself. 2010 Oct;1(4):299-309. doi: 10.4161/self.1.4.13560.
2
Multiple myeloma presenting as CEA-producing rectal cancer.以产生癌胚抗原的直肠癌形式出现的多发性骨髓瘤。
Rare Tumors. 2010 Mar 31;2(1):e4. doi: 10.4081/rt.2010.e4.
3
Cancer risks in ulcerative colitis patients.溃疡性结肠炎患者的癌症风险。
Int J Cancer. 2008 Sep 15;123(6):1417-21. doi: 10.1002/ijc.23666.
4
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.对国际骨髓瘤工作组的10549例患者进行的分析显示，50岁以下患者的骨髓瘤具有更有利的特征，生存率更高。
Blood. 2008 Apr 15;111(8):4039-47. doi: 10.1182/blood-2007-03-081018. Epub 2008 Feb 11.
5
Association of multiple myeloma and inflammatory bowel diseases.多发性骨髓瘤与炎症性肠病的关联。
Dig Dis Sci. 2008 Mar;53(3):863-4. doi: 10.1007/s10620-007-9932-z. Epub 2007 Aug 24.
6
Review article: multiple myeloma and inflammatory bowel disease.
Dig Dis Sci. 2007 Sep;52(9):2022-8. doi: 10.1007/s10620-006-9165-6. Epub 2007 Apr 10.
7
Genetics of Crohn disease, an archetypal inflammatory barrier disease.克罗恩病的遗传学，一种典型的炎症性屏障疾病。
Nat Rev Genet. 2005 May;6(5):376-88. doi: 10.1038/nrg1607.
8
International staging system for multiple myeloma.多发性骨髓瘤国际分期系统
J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4.
9
Post-transplant plasma cell myeloma and polymorphic lymphoproliferative disorder with monoclonal serum protein occurring in solid organ transplant recipients.实体器官移植受者中出现的移植后浆细胞骨髓瘤和伴有单克隆血清蛋白的多形性淋巴增殖性疾病。
Mod Pathol. 2004 Apr;17(4):389-94. doi: 10.1038/modpathol.3800080.
10
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment.重组人可溶性肿瘤坏死因子（TNF）受体（p75）融合蛋白（TNFR:Fc；恩利）用于难治性多发性骨髓瘤患者的初步研究：治疗期间血浆TNFα水平升高
Leuk Res. 2003 May;27(5):375-80. doi: 10.1016/s0145-2126(02)00082-6.
Zotero 插件